Iterum Therapeutics(ITRM) - 2025 Q2 - Quarterly Results

EXHIBIT 99.1 Iterum Therapeutics Reports Second Quarter 2025 Financial Results -- Launch of ORLYNVAHTM Expected August 2025— --Cash Runway into 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, August 5, 2025 -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported financial results for the secon ...